Clinical Study on Ttreatment of Acute Cerebral Infarction with Xuesetong Injection combined with Low Molecular Weight Heparin
10.3760/cma.j.issn.1673-4246.2009.01.011
- VernacularTitle:血塞通联合低分子肝素治疗急性脑梗死的临床研究
- Author:
Wensheng HU
- Publication Type:Journal Article
- Keywords:
XueSeTong injection;
Low-molecular-weight Heparin(LMWH);
Cerebral infarction
- From:
International Journal of Traditional Chinese Medicine
2009;31(1):24-25
- CountryChina
- Language:Chinese
-
Abstract:
Ubjective To evaluate the clinical effects of Xuesetong injecfion combined with Low-molecular-weight Heparin (LMWH) on the treatment of acute cerebral infarction (ACI).Methotis 101 cases of ACI pafiens were randomly divided into three groups:a group one with thirty-three patients were treated only with 5000 IU LMWH twice daily subcutaneously;a group two with thirty-four patients were treated with only 400 mg Xuesetong injection,one daily by intravenous drip;and a group thtee with thirty-four patients were treated with enoxaparin and Xuesetong injection.All the three groups were treated for 14 days.Impaired neurological function score,blood routine,functions of liver and kidney,blood coagulating funcfion were examined before and after the treatment.Results Significant effective rate and the effective rate of the group three were 71%and 91%respectively,higher than the other two groups(P＜0.05 or P＜0.01).No severe adverse reactions were found after the treatment.Conclusion Enoxaparin combined with Xuesetong injection is an effective regimen for the treatment of acute cerebral infarction.
